Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Teleflex Incorporated, 3 years.
Teleflex Incorporated
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 5, 2025 | Jazz Pharmaceuticals plc | Sold back to the company | −4,088 | $138.95 | $568,028 |
| Feb 27, 2025 | Jazz Pharmaceuticals plc | Open-market sale | −3,800 | $144.87 | $550,506 |
| Feb 27, 2025 | Jazz Pharmaceuticals plc | Grant or award | +12,518 | — | — |
| Feb 27, 2025 | Jazz Pharmaceuticals plc | Grant or award | +5,778 | — | — |
| Jan 17, 2025 | Jazz Pharmaceuticals plc | Grant or award | +5,864 | — | — |
| Jan 17, 2025 | Jazz Pharmaceuticals plc | Shares withheld for tax | −1,905 | $122.62 | $233,591 |
| Nov 8, 2024 | Jazz Pharmaceuticals plc | Open-market sale | −3,700 | $123.41 | $456,617 |
| May 7, 2024 | Teleflex Incorporated | Grant or award | +649 | — | — |
| May 3, 2024 | Jazz Pharmaceuticals plc | Open-market sale | −5,000 | $109.65 | $548,250 |
| Mar 5, 2024 | Jazz Pharmaceuticals plc | Shares withheld for tax | −3,432 | $117.53 | $403,363 |
| Mar 1, 2024 | Jazz Pharmaceuticals plc | Grant or award | +12,348 | — | — |
| Jan 17, 2024 | Jazz Pharmaceuticals plc | Grant or award | +5,087 | — | — |
| Jan 17, 2024 | Jazz Pharmaceuticals plc | Shares withheld for tax | −1,656 | $119.13 | $197,279 |
| Sep 1, 2023 | Jazz Pharmaceuticals plc | Open-market sale | −1,500 | $144.25 | $216,375 |
| Aug 15, 2023 | Jazz Pharmaceuticals plc | Open-market sale | −750 | $139.59 | $104,693 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.